Fidelity Disruptive Medicine ETF (FMED) Institutional Ownership $25.16 +0.09 (+0.36%) (As of 12/24/2024 01:48 PM ET) Add Compare Share Share Ownership Stock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Fidelity Disruptive Medicine ETF (NASDAQ:FMED)Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$2.90MNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$1.74M Get FMED Insider Trade Alerts Want to know when executives and insiders are buying or selling Fidelity Disruptive Medicine ETF stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data FMED Institutional Buying and Selling by Quarter Ad Insiders ExposedMysterious drone activity triggers massive 1,366% surgeIf mysterious drones buzzing over the East Coast weren’t on your radar this year, you’re not alone. But here’s what you really need to know: An early warning signal tipped off investors to a tiny drone stock that later skyrocketed 1,366%.👉 Click here now to see how this signal works. Fidelity Disruptive Medicine ETF Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/15/2024 Jane Street Group LLC61,342$1.61M0.0%+200.4%2.921% 11/13/2024 FMR LLC663,600$17.45M0.0%-9.1%31.600% 10/24/2024 Wealth Enhancement Advisory Services LLC539,827$14.19M0.0%+3.7%25.464% 7/16/2024 Wealth Enhancement Advisory Services LLC520,587$12.53M0.0%+4.8%24.556% 4/16/2024 Wealth Enhancement Advisory Services LLC496,857$12.68M0.0%+6.3%23.437% 11/13/2023 FMR LLC737,997$16.33M0.0%-2.6%34.811% (Data available from 1/1/2016 forward) FMED Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of FMED shares? During the previous two years, the following institutional investors and hedge funds held shares of Fidelity Disruptive Medicine ETF shares: FMR LLC ($17.45M), and Wealth Enhancement Advisory Services LLC ($14.19M), Jane Street Group LLC ($1.61M).Learn more on FMED's institutional investors. Which institutional investors have been buying Fidelity Disruptive Medicine ETF stock? The following institutional investors have purchased Fidelity Disruptive Medicine ETF stock in the last 24 months: Wealth Enhancement Advisory Services LLC ($72.31K), and Jane Street Group LLC ($40.92K). How much institutional buying is happening at Fidelity Disruptive Medicine ETF? Institutional investors have bought a total of 113,233 shares in the last 24 months. This purchase volume represents approximately $2.90M in transactions. Which Fidelity Disruptive Medicine ETF major shareholders have been selling company stock? The following institutional investors have sold Fidelity Disruptive Medicine ETF stock in the last 24 months: FMR LLC ($85.94K). How much institutional selling is happening at Fidelity Disruptive Medicine ETF? Institutional investors have sold a total of 85,936 shares in the last 24 months. This volume of shares sold represents approximately $2.18M in transactions. Related Companies SPRX Institutional Ownership FDCF Institutional Ownership EBIZ Institutional Ownership AGNG Institutional Ownership FDFF Institutional Ownership VPN Institutional Ownership SARK Institutional Ownership CANC Institutional Ownership MAGX Institutional Ownership OZEM Institutional Ownership This page (NASDAQ:FMED) was last updated on 12/25/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fidelity Disruptive Medicine ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Fidelity Disruptive Medicine ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.